Complement C4 / C4a Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61313r |
| Product Name | Complement C4 / C4a Recombinant Antibody |
| Applications |
WB
ICC/IF
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human Complement C4 A |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 720 |
| Swiss Prot | P0C0L4 |
| Subcellular location | Secreted |
| Synonyms | Acidic C4; Acidic complement C4; Basic C4; Basic complement C4; C4A; C4A2; C4A3; C4A4; C4A6; C4AD; C4B1; C4B12; C4B2; C4B3; C4BD; C4F; C4S; CPAMD2; CPAMD3. |
| Background | Non-enzymatic component of C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. |
| Application Dilution | |
| WB | 1:300-5000 |
| ICC/IF | 1:50-100 |
Frequently asked questions
Which applications is Complement C4 / C4a Recombinant Antibody (bsm-61313R) validated for, and at what dilution?
bsm-61313R is validated for WB (1:300-5000); ICC/IF (1:50-100). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Complement C4 / C4a Recombinant Antibody (bsm-61313R) react with?
Tested reactivity: Human.
How should bsm-61313R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise Complement C4 / C4a Recombinant Antibody (bsm-61313R)?
KLH conjugated synthetic peptide derived from human Complement C4 A
